NCT04269265View on ClinicalTrials.gov

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

October 23, 2023

Study Completion Date

October 23, 2023

Conditions
Yellow Fever
Interventions
BIOLOGICAL

Yellow Fever Vaccine

YF-VAX®, Yellow Fever Vaccine, for subcutaneous use

Trial Locations (2)

10005

Joint Clinical Research Centre, Kampala

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Minnesota

OTHER

NCT04269265 - The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination | Biotech Hunter | Biotech Hunter